CN115737515A - Skin anti-aging composition containing boscalid and psoralea fruit phenol and production process thereof - Google Patents
Skin anti-aging composition containing boscalid and psoralea fruit phenol and production process thereof Download PDFInfo
- Publication number
- CN115737515A CN115737515A CN202211478665.4A CN202211478665A CN115737515A CN 115737515 A CN115737515 A CN 115737515A CN 202211478665 A CN202211478665 A CN 202211478665A CN 115737515 A CN115737515 A CN 115737515A
- Authority
- CN
- China
- Prior art keywords
- stirring
- cooling
- oil phase
- button
- percent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003712 anti-aging effect Effects 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 239000005740 Boscalid Substances 0.000 title claims abstract description 15
- 229940118790 boscalid Drugs 0.000 title claims abstract description 15
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 title claims abstract description 15
- 241001446509 Psoralea Species 0.000 title claims abstract description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 title claims description 8
- 238000004519 manufacturing process Methods 0.000 title abstract description 10
- 235000013399 edible fruits Nutrition 0.000 title description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 claims abstract description 22
- DDADCBXAKYGDEH-UHFFFAOYSA-N 2-(3-hydroxypropyl)oxane-2,3,4-triol Chemical compound OCCCC1(O)OCCC(O)C1O DDADCBXAKYGDEH-UHFFFAOYSA-N 0.000 claims abstract description 11
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 claims abstract description 11
- YDSVPIYLRFZLAT-UHFFFAOYSA-N C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N Chemical compound C(C)(=O)O.C(C)(=O)O.NC(CCC(=O)NCC1=CC=CC=C1)N YDSVPIYLRFZLAT-UHFFFAOYSA-N 0.000 claims abstract description 11
- 108010016626 Dipeptides Proteins 0.000 claims abstract description 11
- 239000002502 liposome Substances 0.000 claims abstract description 11
- 239000008213 purified water Substances 0.000 claims abstract description 9
- 239000002199 base oil Substances 0.000 claims abstract description 7
- 238000003756 stirring Methods 0.000 claims description 51
- 239000012071 phase Substances 0.000 claims description 35
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 31
- 238000001816 cooling Methods 0.000 claims description 25
- -1 polydimethylsiloxane Polymers 0.000 claims description 25
- 238000010438 heat treatment Methods 0.000 claims description 22
- 229930182478 glucoside Natural products 0.000 claims description 20
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 16
- 239000003921 oil Substances 0.000 claims description 16
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 12
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 11
- 229920006037 cross link polymer Polymers 0.000 claims description 11
- 239000000498 cooling water Substances 0.000 claims description 9
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 8
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 8
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 8
- KZTJQXAANJHSCE-OIDHKYIRSA-N N-octodecanoylsphinganine Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC KZTJQXAANJHSCE-OIDHKYIRSA-N 0.000 claims description 8
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 8
- 229940106189 ceramide Drugs 0.000 claims description 8
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 8
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims description 8
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 8
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 8
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 8
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 8
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 7
- 239000004475 Arginine Substances 0.000 claims description 7
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 7
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims description 7
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims description 7
- 230000003213 activating effect Effects 0.000 claims description 7
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 7
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 7
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 7
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims description 7
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 7
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 7
- 229940100460 peg-100 stearate Drugs 0.000 claims description 7
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 claims description 7
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims description 6
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 6
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 6
- 229960003237 betaine Drugs 0.000 claims description 6
- PXTQQOLKZBLYDY-UHFFFAOYSA-N bis(2-ethylhexyl) carbonate Chemical compound CCCCC(CC)COC(=O)OCC(CC)CCCC PXTQQOLKZBLYDY-UHFFFAOYSA-N 0.000 claims description 6
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 6
- 150000008131 glucosides Chemical class 0.000 claims description 6
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 claims description 6
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 claims description 6
- 239000000787 lecithin Substances 0.000 claims description 6
- 235000010445 lecithin Nutrition 0.000 claims description 6
- 229940067606 lecithin Drugs 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229940057910 shea butter Drugs 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- 230000001804 emulsifying effect Effects 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 4
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims description 4
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 4
- KQEQPUBSXXOUGC-MLCQCVOFSA-N (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-1-acetylpyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(C)=O)C(O)=O KQEQPUBSXXOUGC-MLCQCVOFSA-N 0.000 claims description 4
- ITIMHIATVYROGF-XWUOBKMESA-N (3S)-3-[[(2S)-2-acetamido-6-aminohexanoyl]amino]-4-[[(2S)-1-[[(1S)-1-carboxy-2-(4-hydroxyphenyl)ethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid Chemical compound CC(C)[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O ITIMHIATVYROGF-XWUOBKMESA-N 0.000 claims description 4
- QNZANUZIBYJBIN-XSWJXKHESA-N (3s)-3-[[(2s)-2-acetamido-5-amino-5-oxopentanoyl]amino]-4-[[(2s)-1-[[(1s)-1-carboxy-2-(1h-imidazol-5-yl)ethyl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid Chemical compound NC(=O)CC[C@H](NC(C)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 QNZANUZIBYJBIN-XSWJXKHESA-N 0.000 claims description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 4
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 claims description 4
- SCVVSSZVLZQUDZ-UHFFFAOYSA-N 3-methyl-2,6-dihydro-1H-pyrimidine-2-carboxylic acid Chemical compound CN1C(NCC=C1)C(=O)O SCVVSSZVLZQUDZ-UHFFFAOYSA-N 0.000 claims description 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 4
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 claims description 4
- 241001506047 Tremella Species 0.000 claims description 4
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 claims description 4
- 229940086540 acetyl tetrapeptide-9 Drugs 0.000 claims description 4
- 229960000458 allantoin Drugs 0.000 claims description 4
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 4
- 229940036350 bisabolol Drugs 0.000 claims description 4
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 4
- 235000012000 cholesterol Nutrition 0.000 claims description 4
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims description 4
- 150000004676 glycans Chemical class 0.000 claims description 4
- 229940075529 glyceryl stearate Drugs 0.000 claims description 4
- 229940031575 hydroxyethyl urea Drugs 0.000 claims description 4
- 229920000058 polyacrylate Polymers 0.000 claims description 4
- 229920001282 polysaccharide Polymers 0.000 claims description 4
- 239000005017 polysaccharide Substances 0.000 claims description 4
- 229940064064 purslane extract Drugs 0.000 claims description 4
- 229930002330 retinoic acid Natural products 0.000 claims description 4
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 claims description 4
- 229960001727 tretinoin Drugs 0.000 claims description 4
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- 241001369613 Stephania tetrandra Species 0.000 claims description 3
- 239000008346 aqueous phase Substances 0.000 claims description 3
- 229940083913 c14-22 alcohols Drugs 0.000 claims description 3
- 229940011399 escin Drugs 0.000 claims description 3
- 229930186222 escin Natural products 0.000 claims description 3
- 229960005150 glycerol Drugs 0.000 claims description 3
- 244000226566 Psoralea corylifolia Species 0.000 claims description 2
- KOGFZZYPPGQZFZ-QVAPDBTGSA-N (2s,3r,4s,5r)-2-(2-hydroxypropyl)oxane-3,4,5-triol Chemical compound CC(O)C[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O KOGFZZYPPGQZFZ-QVAPDBTGSA-N 0.000 claims 1
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 claims 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 claims 1
- 229940117895 bakuchiol Drugs 0.000 claims 1
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 abstract description 2
- 108010035532 Collagen Proteins 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 229920001436 collagen Polymers 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 238000003786 synthesis reaction Methods 0.000 abstract description 2
- 235000011187 glycerol Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 5
- 239000006071 cream Substances 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- WVTKBKWTSCPRNU-KYJUHHDHSA-N (+)-Tetrandrine Chemical compound C([C@H]1C=2C=C(C(=CC=2CCN1C)OC)O1)C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@@H]2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-KYJUHHDHSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 2
- JFQWHJPQSSMFMH-UHFFFAOYSA-N methyl 4,5,6-trimethylpyrimidine-2-carboxylate Chemical compound COC(=O)C1=NC(=C(C(=N1)C)C)C JFQWHJPQSSMFMH-UHFFFAOYSA-N 0.000 description 2
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 2
- YFESOSRPNPYODN-RSMWSHJLSA-N (2s,3s,4s,5r,6r)-6-[[(4s,6ar,6bs,8r,8ar,9r,10r,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(z)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3,5-bis[[(2s,3r,4s, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(\C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O.O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)OC1CC[C@]2(C)C3CC=C4[C@@]([C@@]3(CCC2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(CC14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YFESOSRPNPYODN-RSMWSHJLSA-N 0.000 description 1
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WVTKBKWTSCPRNU-UHFFFAOYSA-N rac-Tetrandrin Natural products O1C(C(=CC=2CCN3C)OC)=CC=2C3CC(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2CC2N(C)CCC3=CC(OC)=C(OC)C1=C23 WVTKBKWTSCPRNU-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Abstract
The invention relates to the technical field of organic synthetic chemicals, and particularly discloses a skin anti-aging composition containing boscalid and psoralea corylifoliol and a production process thereof, wherein the composition comprises, by mass, 1% -10% of hydroxypropyl tetrahydropyrane triol, 0.5% -2% of liposome psoralea corylifoliol, 0.05% -0.1% of dipeptide diaminobutyrylbenzyl amide diacetate, 11.9% -21% of a base oil phase, 4.656% -11.252% of a base water phase and 60.648% -79.894% of purified water. By adding the hydroxypropyl tetrahydropyrane triol, the liposome psoralen and the dipeptide diaminobutyrylbenzylamide diacetate, the vitriol can promote the synthesis of collagen, so that the skin has stronger elasticity, fine lines of the neck are improved, and the anti-aging capability is achieved.
Description
Technical Field
The invention relates to the technical field of organic synthetic chemicals, in particular to a vitreochrome bavacrol skin anti-aging composition and a production process thereof.
Background
At present, cosmetics are widely used by individuals to modify or improve the appearance thereof, and some beauty cosmetics have a good beauty-maintaining and repairing effect.
However, in the prior art, the anti-aging cosmetic products are few, and the anti-aging products have poor effects and cannot achieve the required effects.
Disclosure of Invention
The invention aims to provide a skin anti-aging composition containing boscalid and psoralea corylifolia phenol and a production process thereof, and aims to solve the technical problems that in the prior art, anti-aging beauty products are few, the anti-aging products are poor in effect, and the required effect cannot be achieved.
In order to achieve the purpose, the vitriol-psoralen skin anti-aging composition and the production process thereof adopted by the invention comprise, by mass, 3% -5% of hydroxypropyl tetrahydropyrane triol, 0.5% -2% of liposome psoralen, 0.05% -0.1% of dipeptide diaminobutyrylbenzyl amide diacetate, 11.9% -21% of a base oil phase, 4.656% -11.252% of a base water phase and 60.648% -79.894% of purified water.
Wherein the base oil phase comprises a combination of any of cetearyl glucoside, PEG-100 stearate, cetearyl alcohol, ceramide NS/ceramide NG, pentaerythritol tetra (ethylhexanoate), caprylic/capric triglyceride, shea butter, diethylhexyl carbonate, polydimethylsiloxane, oxidized lecithin, hydrogenated lecithin, tocopheryl acetate, C14-22 alcohols, C12-20 alkyl glucosides, glyceryl stearate, cholesterol, glycerol, 1.3 butylene glycol, sodium PCA, disodium EDTA, polyacrylate crosspolymer, sodium hyaluronate, tremella polysaccharide, and allantoin.
Wherein the base aqueous phase comprises a combination of any of glycerol, hydroxyethyl urea, betaine, glyceryl polyether-26, glyceryl glucoside, acrylic acid/C10-30 alkanol acrylate crosspolymer, 1, 2-hexanediol, arginine, essential oils, 1.3 butanediol, disodium EDTA, gamma-aminobutyric acid, sodium hyaluronate, bisabolol, ginger root extract, hydroxyppinacolone retinoic acid ester, purslane extract, stephania tetrandra extract, p-hydroxyacetophenone, glyceryl glucoside, tetramethylpyrimidine carboxylic acid, escin, tripeptide-1, oligopeptide-3, oligopeptide-6, acetyl tetrapeptide-9, acetyl tetrapeptide-11, and acetyl tetrapeptide-2.
The invention also provides a production process of the boscalid-ochron bavacrol skin anti-aging composition, and the preparation of the boscalid-ochron bavacrol skin anti-aging composition comprises the following steps:
turning on a power supply, adding the cetearyl glucoside, the PEG-100 stearate, the cetearyl alcohol, the ceramide NS/ceramide NG, the pentaerythritol tetra (ethyl hexanoate), the caprylic/capric triglyceride, the shea butter, the diethylhexyl carbonate, the polydimethylsiloxane, the oxidized lecithin, and the tocopheryl acetate into an oil phase pan, activating a heating button or a steam valve and a stirring button, and stirring at a speed of 20 rpm;
adding the glycerol, the hydroxyethyl urea, the betaine, the glyceryl polyether-26, the glyceryl glucoside, the acrylic acid/C10-30 alkanol acrylate crosspolymer, and the purified water to an aqueous kettle, activating a heating button or a steam valve and a stirring button, and stirring at 20 rpm;
heating the water phase pot to 95-100 ℃, and heating the oil phase pot to 82-85 ℃;
starting an emulsifying pot heating button or a steam valve for preheating, vacuumizing to-0.04 MPa, firstly vacuumizing the water phase pot and then vacuumizing the oil phase pot, starting stirring, keeping the temperature at about 85 ℃, drying the oil phase, stopping stirring, starting a homogenizing button, homogenizing for 3 minutes at the homogenizing speed of 4000 revolutions per minute, and keeping the vacuum at-0.04 MPa;
starting a cooling water valve and a drain valve, cooling to 40-45 ℃, adding the hydroxypropyl tetrahydropyrane triol, the liposome psoralen and the dipeptide diaminobutyryl benzylamide diacetate from an adding port, continuously stirring and cooling, wherein the stirring speed is 30 r/min, and keeping the vacuum at-0.04 Mpa;
starting a cooling water valve and a drain valve, cooling to below 40 ℃, adding the p-hydroxyacetophenone, the 1, 2-hexanediol, the arginine and the essential oil, continuously stirring and cooling, wherein the stirring speed is 20 r/min, and keeping the vacuum to be 0.04MPa;
cooling to below 32 ℃, and stopping stirring;
and (4) subpackaging the inner bottles, putting the inner bottles into an outer paper box, packaging and coding, and finally completing the preparation of the psoralea fruit phenol skin anti-aging composition with the glass color.
The invention relates to a skin anti-aging composition containing boscalid and psoralen and a production process, which has the beneficial effects that: the hydroxypropyl tetrahydropyrane triol, the liposome psoralen and the dipeptide diaminobutyryl benzyl amide diacetate are added, the hydroxypropyl tetrahydropyrane triol can promote the synthesis of collagen, so that the skin has stronger elasticity, the fine lines of the neck are improved, and the anti-aging capability is achieved.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings used in the description of the embodiments or the prior art will be briefly described below, it is obvious that the drawings in the following description are only some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to the drawings without creative efforts.
FIG. 1 is a process flow diagram of example 1 of the present invention.
Figure 2 is a process step flow diagram of example 2 of the present invention.
Figure 3 is a process step flow diagram of example 3 of the present invention.
Detailed Description
Reference will now be made in detail to embodiments of the present invention, examples of which are illustrated in the accompanying drawings, wherein like reference numerals refer to the same or similar elements or elements having the same or similar functions throughout. The embodiments described below with reference to the accompanying drawings are illustrative and intended to explain the present invention and should not be construed as limiting the present invention.
The invention provides a vitreochrome psoralen skin anti-aging composition which comprises, by mass, 3% -5% of hydroxypropyl tetrahydropyrane triol, 0.5% -2% of liposome psoralen, 0.05% -0.1% of dipeptide diaminobutyrylbenzylamide diacetate, 11.9% -21% of a base oil phase, 4.656% -11.252% of a base water phase and 60.648% -79.894% of purified water.
The base oil phase comprises a combination of any of cetearyl glucoside, PEG-100 stearate, cetearyl alcohol, ceramide NS/ceramide NG, pentaerythritol tetrakis (ethyl hexanoate), caprylic/capric triglyceride, shea butter, diethylhexyl carbonate, polydimethylsiloxane, oxidized lecithin, hydrogenated lecithin, tocopheryl acetate, C14-22 alcohols, C12-20 alkyl glucosides, glyceryl stearate, cholesterol, glycerol, 1.3 butylene glycol, sodium PCA, disodium EDTA, polyacrylate crosspolymer, sodium hyaluronate, tremella polysaccharide, and allantoin.
The base aqueous phase comprises a combination of any of glycerol, hydroxyethyl urea, betaine, glyceryl polyether-26, glyceryl glucoside, acrylic acid/C10-30 alkanol acrylate crosspolymer, 1, 2-hexanediol, arginine, essential oils, 1.3 butanediol, disodium EDTA, gamma-aminobutyric acid, sodium hyaluronate, bisabolol, ginger root extract, hydroxyppinacolone retinoic acid ester, purslane extract, tetrandrine extract, p-hydroxyacetophenone, glyceryl glucoside, tetramethylpyrimidine carboxylic acid, escin, tripeptide-1, oligopeptide-3, oligopeptide-6, acetyl tetrapeptide-9, acetyl tetrapeptide-11, and acetyl tetrapeptide-2.
In example 1, referring to fig. 1, the present invention further provides a process for producing the boscalid-related anti-aging composition for skin, which comprises the following steps:
s1: turning on the power supply, adding 2% of said cetearyl glucoside, 2% of said PEG-100 stearate, 3% of said cetearyl alcohol, 0.2% of said ceramide NS/ceramide NG, 5% of said pentaerythritol tetraester, 3% of said caprylic/capric triglyceride, 2% of said shea butter, 2% of said diethylhexyl carbonate, 1% of said polydimethylsiloxane, 0.3% of said oxidized lecithin, and 0.5% of said tocopheryl acetate to the oil phase pan, activating the heating button or steam valve and stirring button, stirring at 20 rpm;
s2: adding 2% of the glycerol, 0.15% of the tetrahydromethylpyrimidine carboxylic acid, 2% of the betaine, 2% of the glyceryl polyether-26, 1% of the glyceryl glucoside, 0.1% of the acrylic acid (ester)/C10-30 alkanol acrylate crosspolymer, and the balance of the purified water to a water phase kettle, activating a heating button or a steam valve and a stirring button, and stirring at a speed of 20 rpm;
s3: heating the water phase pot to 95-100 ℃, and heating the oil phase pot to 82-85 ℃;
s4: starting a heating button or a steam valve of an emulsifying pot for preheating, vacuumizing to-0.04 MPa, firstly vacuumizing the water phase pot and then vacuumizing the oil phase pot, starting stirring, keeping the temperature at about 85 ℃, vacuumizing the oil phase, stopping stirring, starting a homogenizing button, homogenizing for 3 minutes at the homogenizing speed of 4000 revolutions per minute, and keeping the vacuum at-0.04 MPa;
s5: starting a cooling water valve and a drain valve, cooling to 40-45 ℃, adding 5% of hydroxypropyl tetrahydropyrane triol, 1% of liposome psoralen and 0.1% of dipeptide diaminobutyryl benzylamide diacetate from an adding port, continuously stirring and cooling at the stirring speed of 30 revolutions per minute, and keeping the vacuum at-0.04 Mpa;
s6: opening a cooling water valve and a drain valve, cooling to below 40 ℃, adding 0.5% of p-hydroxyacetophenone, 0.5% of 1, 2-hexanediol, 0.1% of arginine and 0.1% of essential oil, continuously stirring and cooling, wherein the stirring speed is 20 revolutions per minute, and keeping the vacuum at-0.04 MPa;
s7: cooling to below 32 ℃, and stopping stirring;
s8: and (4) subpackaging the inner bottles, putting the inner bottles into an outer paper box, packaging and coding, and finally completing the preparation of the psoralea fruit phenol skin anti-aging composition with the glass color.
In embodiment 2, referring to fig. 2, the present invention further provides a process for producing the boscalid-related anti-aging composition for skin, which comprises the following steps:
s1: turning on the power supply, adding 2% of said C14-22 alcohol, 2% of said C12-20 alkyl glucoside, 2% of said PEG-100 stearate, 2% of said glyceryl stearate, 0.1% of said ceramide NS/ceramide NG, 0.5% of said cholesterol, 2% of said caprylic/capric triglyceride, 0.5% of said polydimethylsiloxane, 0.5% of said tocopheryl acetate, and 0.3% of said hydrogenated lecithin to the oil phase pan, activating the heating button or steam valve and stirring button, and stirring at 20 rpm;
s2: adding 4% of the 1.3 butanediol, 0.1% of the EDTA disodium, 0.1% of the acrylic acid (ester)/C10-30 alkanol acrylate cross-linked polymer, 0.05% of the gamma-aminobutyric acid, 0.1% of the sodium hyaluronate and the balance of the purified water into a water phase pot, starting a heating button or a steam valve and a stirring button, and stirring at the speed of 20 revolutions per minute;
s3: heating the water phase pot to 95-100 ℃, and heating the oil phase pot to 82-85 ℃;
s4: starting an emulsifying pot heating button or a steam valve for preheating, vacuumizing to-0.04 MPa, firstly vacuumizing the water phase pot and then vacuumizing the oil phase pot, starting stirring, keeping the temperature at about 85 ℃, drying the oil phase, stopping stirring, starting a homogenizing button, homogenizing for 3 minutes at the homogenizing speed of 4000 revolutions per minute, and keeping the vacuum at-0.04 MPa;
s5: starting a cooling water valve and a drain valve, cooling to 40-45 ℃, adding 3% of hydroxypropyl tetrahydropyrane triol, 0.5% of liposome psoralen and 0.05% of dipeptide diaminobutyryl benzylamide diacetate from an adding port, continuously stirring and cooling at the stirring speed of 30 revolutions per minute, and keeping the vacuum at-0.04 Mpa;
s6: starting a cooling water valve and a drain valve, cooling to below 40 ℃, adding 0.5 percent of p-hydroxyacetophenone, 0.5 percent of 1, 2-hexanediol, 0.1 percent of arginine, 0.1 percent of bisabolol, 0.1 percent of ginger root extract and 0.1 percent of hydroxy pinacolone retinoic acid ester, continuously stirring and cooling, wherein the stirring speed is 20 r/min, and keeping vacuum at-0.04 MPa;
s7: cooling to below 32 ℃, and stopping stirring;
s8: and (4) subpackaging the inner bottles, putting the inner bottles into an outer paper box, packaging and coding, and finally completing the preparation of the psoralea fruit phenol skin anti-aging composition with the glass color.
In embodiment 3, referring to fig. 3, the present invention further provides a production process of the boscalid glabrous skin anti-aging composition, and the preparation of the boscalid glabrous skin anti-aging composition comprises the following steps:
s1: turning on a total power supply, and adding 4% of the glycerin, 4% of the 1.3 butanediol, 4% of the sodium PCA, 0.1% of the disodium EDTA, 0.3% of the polyacrylate cross-linked polymer, 0.1% of the sodium hyaluronate, 0.05% of the tremella polysaccharide, 0.3% of the hydrogenated lecithin, 0.3% of the allantoin and the balance of purified water to 100% into an emulsifying pot;
s2: starting a heating button or a steam valve and a stirring button, stirring at 20 revolutions per minute, and heating to 95-100 ℃;
s3: opening a cooling water valve and a drain valve, cooling to 40-45 ℃, adding 5% of hydroxypropyl tetrahydropyrane triol, 2% of liposome psoralen, 0.05% of dipeptide diaminobutyryl benzylamide diacetate and 0.1% of ceramide NS/ceramide NG from an adding port, uniformly stirring and cooling, wherein the stirring speed is 20 revolutions per minute;
s4: cooling to below 40 ℃, adding 2% of the purslane extract, 0.1% of the stephania tetrandra extract, 0.5% of the p-hydroxyacetophenone, 0.5% of the 1, 2-hexanediol, 1% of the glycerol glucoside, 0.2% of the tetrahydromethylpyrimidine carboxylic acid, 0.2% of the aescin, 0.15% of the tripeptide-1, 0.001% of the oligopeptide-3, 0.001% of the oligopeptide-6, 0.001% of the acetyl tetrapeptide-9, 0.001% of the acetyl tetrapeptide-11 and 0.001% of the acetyl tetrapeptide-2 from an addition port, stirring uniformly and cooling, wherein the stirring speed is 20 rpm;
s5: cooling to below 32 ℃, and stopping stirring;
s6: subpackaging an inner bottle, an outer paper box, packaging and coding, and finally completing the preparation of the psoralea corylifolia-phenol skin anti-aging composition.
According to the production process, the cream with the boscalid can be prepared in the embodiment 1, the cream with the boscalid can be prepared in the embodiment 2, the cream with the boscalid can be prepared in the embodiment 3, and the repairing essence with the boscalid can be prepared in the embodiment 3, so that the cream can be applied to different types of products.
While the invention has been described with reference to a preferred embodiment, it will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention.
Claims (4)
1. A skin anti-aging composition containing psoralea corylifolia phenol with vitrescence comprises the following components in parts by mass,
3 to 5 percent of hydroxypropyl tetrahydropyrane triol, 0.5 to 2 percent of liposome bakuchiol, 0.05 to 0.1 percent of dipeptide diaminobutyryl benzylamide diacetate, 11.9 to 21 percent of base oil phase, 4.656 to 11.252 percent of base water phase and 60.648 to 79.894 percent of purified water.
2. The boscalid-related skin antiaging composition according to claim 1, wherein,
the base oil phase comprises a combination of any of cetearyl glucoside, PEG-100 stearate, cetearyl alcohol, ceramide NS/ceramide NG, pentaerythritol tetrakis (ethyl hexanoate), caprylic/capric triglyceride, shea butter, diethylhexyl carbonate, polydimethylsiloxane, oxidized lecithin, hydrogenated lecithin, tocopheryl acetate, C14-22 alcohols, C12-20 alkyl glucosides, glyceryl stearate, cholesterol, glycerol, 1.3 butylene glycol, sodium PCA, disodium EDTA, polyacrylate crosspolymer, sodium hyaluronate, tremella polysaccharide, and allantoin.
3. The vitreopsoralen-containing skin anti-aging composition of claim 2,
the base aqueous phase comprises a combination of any of glycerol, hydroxyethyl urea, betaine, glyceryl polyether-26, glyceryl glucoside, acrylic acid/C10-30 alkanol acrylate crosspolymer, 1, 2-hexanediol, arginine, essential oils, 1.3 butylene glycol, disodium EDTA, gamma-aminobutyric acid, sodium hyaluronate, bisabolol, ginger root extract, hydroxyppinanone retinoic acid ester, purslane extract, stephania tetrandra extract, p-hydroxyacetophenone, glyceryl glucoside, tetrahydromethylpyrimidine carboxylic acid, escin, tripeptide-1, oligopeptide-3, oligopeptide-6, acetyl tetrapeptide-9, acetyl tetrapeptide-11, and acetyl tetrapeptide-2.
4. A process for producing the boscalid umbellate pore fungus phenol skin anti-aging composition according to claim 3, comprising the steps of:
turning on a power supply, adding the cetearyl glucoside, the PEG-100 stearate, the cetearyl alcohol, the ceramide NS/ceramide NG, the pentaerythritol tetra (ethyl hexanoate), the caprylic/capric triglyceride, the shea butter, the diethylhexyl carbonate, the polydimethylsiloxane, the oxidized lecithin, and the tocopheryl acetate to an oil phase pan, activating a heating button or a steam valve and a stirring button, and stirring at a speed of 20 rpm;
adding the glycerol, the tetrahydro-methyl pyrimidine carboxylic acid, the betaine, the glyceryl polyether-26, the glyceryl glucoside, the acrylic acid/C10-30 alkanol acrylate crosspolymer, and the purified water to an aqueous kettle, activating a heating button or a steam valve and a stirring button, and stirring at 20 rpm;
heating the water phase pot to 95-100 ℃, and heating the oil phase pot to 82-85 ℃;
starting a heating button or a steam valve of an emulsifying pot for preheating, vacuumizing to-0.04 MPa, firstly vacuumizing the water phase pot and then vacuumizing the oil phase pot, starting stirring, keeping the temperature at about 85 ℃, vacuumizing the oil phase, stopping stirring, starting a homogenizing button, homogenizing for 3 minutes at the homogenizing speed of 4000 revolutions per minute, and keeping the vacuum at-0.04 MPa;
opening a cooling water valve and a drain valve, cooling to 40-45 ℃, adding the hydroxypropyl tetrahydropyran triol, the liposome psoralen and the dipeptide diaminobutyryl benzylamide diacetate from an adding port, continuously stirring and cooling at the stirring speed of 30 r/min, and keeping the vacuum at-0.04 Mpa;
opening a cooling water valve and a drain valve, cooling to below 40 ℃, adding the p-hydroxyacetophenone, the 1, 2-hexanediol, the arginine and the essential oil, continuously stirring and cooling, wherein the stirring speed is 20 r/min, and keeping the vacuum at-0.04 MPa;
cooling to below 32 ℃, and stopping stirring;
subpackaging an inner bottle, an outer paper box, packaging and coding, and finally completing the preparation of the psoralea corylifolia-phenol skin anti-aging composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211478665.4A CN115737515A (en) | 2022-11-23 | 2022-11-23 | Skin anti-aging composition containing boscalid and psoralea fruit phenol and production process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211478665.4A CN115737515A (en) | 2022-11-23 | 2022-11-23 | Skin anti-aging composition containing boscalid and psoralea fruit phenol and production process thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115737515A true CN115737515A (en) | 2023-03-07 |
Family
ID=85336500
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211478665.4A Pending CN115737515A (en) | 2022-11-23 | 2022-11-23 | Skin anti-aging composition containing boscalid and psoralea fruit phenol and production process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115737515A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110448472A (en) * | 2019-09-25 | 2019-11-15 | 珠海伊斯佳科技股份有限公司 | A kind of facial mask liquid and preparation method thereof that water oil two-phase mixes immediately |
| CN112402310A (en) * | 2020-10-30 | 2021-02-26 | 广州市妆妍生物技术有限公司 | Vitreous chromogen polypeptide anti-wrinkle eye cream and preparation method thereof |
| CN113509442A (en) * | 2021-06-21 | 2021-10-19 | 浙江宜格企业管理集团有限公司 | A liposome containing bakuchiol and its preparation method |
| CN113616566A (en) * | 2021-08-12 | 2021-11-09 | 北京妍之素生物科技有限公司 | Skin care essence for tightening skin and preparation method thereof |
| CN113876609A (en) * | 2021-10-29 | 2022-01-04 | 湖北省麦诗特生物科技有限公司 | Anti-aging composition containing hydroxypropyl tetrahydropyrane triol and polypeptide protein and application thereof |
| CN114177104A (en) * | 2021-11-25 | 2022-03-15 | 湖州中科锦肽生物科技有限公司 | Anti-aging face cream |
-
2022
- 2022-11-23 CN CN202211478665.4A patent/CN115737515A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110448472A (en) * | 2019-09-25 | 2019-11-15 | 珠海伊斯佳科技股份有限公司 | A kind of facial mask liquid and preparation method thereof that water oil two-phase mixes immediately |
| CN112402310A (en) * | 2020-10-30 | 2021-02-26 | 广州市妆妍生物技术有限公司 | Vitreous chromogen polypeptide anti-wrinkle eye cream and preparation method thereof |
| CN113509442A (en) * | 2021-06-21 | 2021-10-19 | 浙江宜格企业管理集团有限公司 | A liposome containing bakuchiol and its preparation method |
| CN113616566A (en) * | 2021-08-12 | 2021-11-09 | 北京妍之素生物科技有限公司 | Skin care essence for tightening skin and preparation method thereof |
| CN113876609A (en) * | 2021-10-29 | 2022-01-04 | 湖北省麦诗特生物科技有限公司 | Anti-aging composition containing hydroxypropyl tetrahydropyrane triol and polypeptide protein and application thereof |
| CN114177104A (en) * | 2021-11-25 | 2022-03-15 | 湖州中科锦肽生物科技有限公司 | Anti-aging face cream |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5607921A (en) | Stabilized cosmetic or dermatological composition containing several precursors of the same active agent in order to maximize its release, and use thereof | |
| KR101713357B1 (en) | Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra | |
| CA2397987C (en) | Use of at least a fatty ester for preparing a composition designed to inhibit 5 alpha reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive | |
| Sajna et al. | White biotechnology in cosmetics | |
| JP5497809B2 (en) | Whitening agent | |
| CN107496278A (en) | Carnosine snow face frost | |
| CN106924073A (en) | A kind of replenishing water and preserving moisture facial mask and preparation method thereof | |
| CN110747234B (en) | Preparation method of sophora flower extract | |
| KR102307186B1 (en) | Cosmetic composition having salicylic acid | |
| CN102057047B (en) | Method for producing natural 9-decen-2-one by bioconverting undecylenic acid using a mold, and use in the perfume and food flavoring fields | |
| KR101794416B1 (en) | Cosmetic composition for antioxidation, skin-whitening and anti-wrinkle comprising Amaranth leaf extracts as effective component, and method for preparing Amaranth leaf extracts | |
| CN115737515A (en) | Skin anti-aging composition containing boscalid and psoralea fruit phenol and production process thereof | |
| Křen et al. | Rutinosidase and other diglycosidases: rising stars in biotechnology | |
| KR20200048158A (en) | Composition for antioxidant or improving skin wrinkle containing defatted Perilla frutescens extract | |
| CN107184455A (en) | A kind of natural organic face cream | |
| JP2000191494A (en) | Composition for beauty culture and health | |
| CN101524316B (en) | Acne-removing cream capable of rapidly removing facial acne without leaving marks on face | |
| CN111234953A (en) | Plant extract tableware detergent wrapped by PVA water-soluble film and preparation method thereof | |
| CN108992360A (en) | It is a kind of add natural plant extracts skin care compositions and facial mask preparation method | |
| JP2018158910A (en) | Introductory cosmetics | |
| CN111135128A (en) | A cosmetic composition containing pineapple peel extract and its preparation method | |
| KR102251114B1 (en) | Cosmetic composition for skin moisturizing or anti-wrinkle comprising hydrolyzed extract of Turbo cornutus viscera as effective component | |
| KR102140031B1 (en) | A cosmetic and a bath composition containing the active ingredient of Buddha's hand | |
| CN102613342A (en) | Tea beverage with hypoglycemic and hypolipidemic effects | |
| JP2011184457A (en) | Anti-aging agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |